

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 4.81617234 |
| 2 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.47990965 |
| 3 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.47990965 |
| 4 | DNA deamination (GO:0045006) | 4.37208332 |
| 5 | positive regulation of B cell differentiation (GO:0045579) | 4.16887910 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.08831324 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 4.08519287 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90949014 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90949014 |
| 10 | amyloid precursor protein catabolic process (GO:0042987) | 3.84002266 |
| 11 | negative regulation of phagocytosis (GO:0050765) | 3.82018769 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79186815 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 3.76019191 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 3.76019191 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71534117 |
| 16 | protein retention in ER lumen (GO:0006621) | 3.70095977 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70009046 |
| 18 | myeloid leukocyte mediated immunity (GO:0002444) | 3.66626918 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.58603353 |
| 20 | endosome to pigment granule transport (GO:0043485) | 3.55671676 |
| 21 | endosome to melanosome transport (GO:0035646) | 3.55671676 |
| 22 | disruption of cells of other organism (GO:0044364) | 3.52975564 |
| 23 | killing of cells of other organism (GO:0031640) | 3.52975564 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.49783157 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.48522961 |
| 26 | defense response to fungus (GO:0050832) | 3.47740450 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45440456 |
| 28 | leukotriene biosynthetic process (GO:0019370) | 3.43461309 |
| 29 | mannose metabolic process (GO:0006013) | 3.40517996 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.39486787 |
| 31 | interferon-gamma secretion (GO:0072643) | 3.34753836 |
| 32 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.31117350 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.30861532 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30861532 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.30861532 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30861532 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30861532 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30861532 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.28693267 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28693267 |
| 41 | signal peptide processing (GO:0006465) | 3.24737700 |
| 42 | pentose-phosphate shunt (GO:0006098) | 3.24719395 |
| 43 | response to fungus (GO:0009620) | 3.24640716 |
| 44 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20778771 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.18982578 |
| 46 | platelet dense granule organization (GO:0060155) | 3.13311933 |
| 47 | megakaryocyte development (GO:0035855) | 3.10666826 |
| 48 | thymic T cell selection (GO:0045061) | 3.06371706 |
| 49 | respiratory burst (GO:0045730) | 3.05399119 |
| 50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04287319 |
| 51 | fucose catabolic process (GO:0019317) | 3.03497175 |
| 52 | L-fucose metabolic process (GO:0042354) | 3.03497175 |
| 53 | L-fucose catabolic process (GO:0042355) | 3.03497175 |
| 54 | mast cell activation (GO:0045576) | 3.03251525 |
| 55 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.02834239 |
| 56 | purine nucleotide salvage (GO:0032261) | 3.02518774 |
| 57 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02397256 |
| 58 | peptide catabolic process (GO:0043171) | 3.00931746 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 2.97135938 |
| 60 | glycolipid catabolic process (GO:0019377) | 2.94518119 |
| 61 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.93189861 |
| 62 | L-serine metabolic process (GO:0006563) | 2.92462580 |
| 63 | leukocyte aggregation (GO:0070486) | 2.92185559 |
| 64 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.91739901 |
| 65 | regulation of growth of symbiont in host (GO:0044126) | 2.91739901 |
| 66 | negative regulation of growth of symbiont in host (GO:0044130) | 2.91739901 |
| 67 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.91739901 |
| 68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89945220 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.88632149 |
| 70 | mature B cell differentiation involved in immune response (GO:0002313) | 2.87777202 |
| 71 | T cell migration (GO:0072678) | 2.86968009 |
| 72 | cotranslational protein targeting to membrane (GO:0006613) | 2.86816027 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86244815 |
| 74 | leukotriene metabolic process (GO:0006691) | 2.86045990 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85421260 |
| 76 | response to type I interferon (GO:0034340) | 2.84845464 |
| 77 | modulation by virus of host process (GO:0019054) | 2.83554548 |
| 78 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83442266 |
| 79 | protein targeting to ER (GO:0045047) | 2.83432465 |
| 80 | positive thymic T cell selection (GO:0045059) | 2.82950626 |
| 81 | mitochondrial calcium ion transport (GO:0006851) | 2.82471270 |
| 82 | response to interferon-beta (GO:0035456) | 2.81492169 |
| 83 | type I interferon signaling pathway (GO:0060337) | 2.81189091 |
| 84 | cellular response to type I interferon (GO:0071357) | 2.81189091 |
| 85 | NADPH regeneration (GO:0006740) | 2.80756013 |
| 86 | purine-containing compound salvage (GO:0043101) | 2.79310918 |
| 87 | amyloid precursor protein metabolic process (GO:0042982) | 2.78990017 |
| 88 | detection of bacterium (GO:0016045) | 2.78960939 |
| 89 | proline biosynthetic process (GO:0006561) | 2.77710964 |
| 90 | protein localization to endoplasmic reticulum (GO:0070972) | 2.77484138 |
| 91 | pinocytosis (GO:0006907) | 2.77099940 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.76787237 |
| 93 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76515946 |
| 94 | exocrine pancreas development (GO:0031017) | 2.76339735 |
| 95 | regulation of histone H3-K27 methylation (GO:0061085) | 2.76073156 |
| 96 | GDP-mannose metabolic process (GO:0019673) | 2.75556684 |
| 97 | defense response to protozoan (GO:0042832) | 2.73390570 |
| 98 | angiotensin maturation (GO:0002003) | 2.72618951 |
| 99 | negative T cell selection (GO:0043383) | 2.69065918 |
| 100 | cellular response to virus (GO:0098586) | 2.67909974 |
| 101 | T cell selection (GO:0045058) | 2.66881877 |
| 102 | digestion (GO:0007586) | 2.66707873 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66399323 |
| 104 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66021864 |
| 105 | regulation of superoxide anion generation (GO:0032928) | 2.64877424 |
| 106 | protein maturation by protein folding (GO:0022417) | 2.63929547 |
| 107 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63640745 |
| 108 | response to peptidoglycan (GO:0032494) | 2.63567997 |
| 109 | detection of other organism (GO:0098543) | 2.61868119 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.60671016 |
| 111 | response to protozoan (GO:0001562) | 2.59479699 |
| 112 | cellular response to interferon-beta (GO:0035458) | 2.58907037 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58609082 |
| 114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58417083 |
| 115 | response to muramyl dipeptide (GO:0032495) | 2.57564135 |
| 116 | lymphocyte migration (GO:0072676) | 2.57317941 |
| 117 | negative regulation of viral release from host cell (GO:1902187) | 2.57293085 |
| 118 | macrophage differentiation (GO:0030225) | 2.57097442 |
| 119 | cellular response to exogenous dsRNA (GO:0071360) | 2.56655327 |
| 120 | viral transcription (GO:0019083) | 2.56582756 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55033832 |
| 122 | response to host (GO:0075136) | 2.55033832 |
| 123 | response to host defenses (GO:0052200) | 2.55033832 |
| 124 | N-acetylneuraminate metabolic process (GO:0006054) | 2.54303321 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.53567884 |
| 126 | modulation by symbiont of host cellular process (GO:0044068) | 2.52265461 |
| 127 | serine family amino acid biosynthetic process (GO:0009070) | 2.52209823 |
| 128 | nucleobase biosynthetic process (GO:0046112) | 2.51944472 |
| 129 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51870581 |
| 130 | ceramide catabolic process (GO:0046514) | 2.51619085 |
| 131 | nucleoside salvage (GO:0043174) | 2.50956765 |
| 132 | B cell receptor signaling pathway (GO:0050853) | 2.50821293 |
| 133 | DNA strand elongation (GO:0022616) | 2.49804131 |
| 134 | tolerance induction (GO:0002507) | 2.49358307 |
| 135 | positive regulation of histone deacetylation (GO:0031065) | 2.48714079 |
| 136 | anterograde synaptic vesicle transport (GO:0048490) | 2.46471509 |
| 137 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.46349361 |
| 138 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.46182992 |
| 139 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45750872 |
| 140 | negative regulation of interleukin-2 production (GO:0032703) | 2.45281912 |
| 141 | cellular response to interleukin-4 (GO:0071353) | 2.45002040 |
| 142 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.44589460 |
| 143 | cholesterol catabolic process (GO:0006707) | 2.44086879 |
| 144 | sterol catabolic process (GO:0016127) | 2.44086879 |
| 145 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.43626656 |
| 146 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43142649 |
| 147 | response to host immune response (GO:0052572) | 2.43142649 |
| 148 | protein insertion into membrane (GO:0051205) | 2.42698051 |
| 149 | macrophage activation involved in immune response (GO:0002281) | 2.42189596 |
| 150 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42139792 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40830227 |
| 152 | lymphoid progenitor cell differentiation (GO:0002320) | 2.39739284 |
| 153 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39387068 |
| 154 | positive regulation of granulocyte differentiation (GO:0030854) | 2.39116372 |
| 155 | T cell homeostasis (GO:0043029) | 2.39100851 |
| 156 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.38555441 |
| 157 | leukocyte mediated cytotoxicity (GO:0001909) | 2.37935553 |
| 158 | negative regulation of B cell apoptotic process (GO:0002903) | 2.37913748 |
| 159 | translational elongation (GO:0006414) | 2.37211196 |
| 160 | translational termination (GO:0006415) | 2.36989409 |
| 161 | pentose metabolic process (GO:0019321) | 2.35924719 |
| 162 | regulation of cholesterol esterification (GO:0010872) | 2.34110171 |
| 163 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.32864125 |
| 164 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.32572818 |
| 165 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32154226 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.31327461 |
| 167 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.30701998 |
| 168 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.28342101 |
| 169 | regulation of mast cell degranulation (GO:0043304) | 2.28250607 |
| 170 | negative regulation of interleukin-6 production (GO:0032715) | 2.27758596 |
| 171 | response to interleukin-4 (GO:0070670) | 2.26509119 |
| 172 | amino sugar catabolic process (GO:0046348) | 2.26110715 |
| 173 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.25714027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.30402862 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.23851599 |
| 3 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17117372 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03431928 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.02502740 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02165923 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97791260 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.88838276 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.88201208 |
| 10 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71279993 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.62002412 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55205919 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.55082891 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52947976 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52879883 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.51903637 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45335250 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37454361 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.33013072 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29373898 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21465621 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20533156 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.20138569 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15923503 |
| 25 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10740490 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10236632 |
| 27 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.09131418 |
| 28 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08802548 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08229381 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.07465390 |
| 31 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06280517 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.02619061 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.01647236 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.00779206 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00564903 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97370291 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89354874 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84030194 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77894969 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77213128 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73651478 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73052466 |
| 43 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.71451031 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.70973809 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70123078 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69219620 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68876686 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68241165 |
| 49 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.66833267 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.66522757 |
| 51 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.66471039 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66449593 |
| 53 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66252180 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64906649 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64583164 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64240092 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62874819 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62844129 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60599646 |
| 60 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59457774 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.58526013 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57468081 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54866505 |
| 64 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.53976600 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53828725 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52757316 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51810757 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51189919 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50912602 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50588910 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.47753514 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46000200 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44957648 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40659055 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40626152 |
| 76 | MYB_26560356_Chip-Seq_TH2_Human | 1.38202283 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38200025 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.37675264 |
| 79 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36615389 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35937793 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35541586 |
| 82 | * MAF_26560356_Chip-Seq_TH1_Human | 1.35129465 |
| 83 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.34989701 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34806372 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33844005 |
| 86 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33070173 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32925429 |
| 88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32142712 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29404316 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28365719 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27862930 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27270323 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26997830 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26380584 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26146241 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26110362 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 1.25526209 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22779404 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22612361 |
| 100 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22490960 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21658000 |
| 102 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21328808 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21324431 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19469030 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18365641 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17920464 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15602843 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15303633 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15231949 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13770246 |
| 111 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13739490 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13634820 |
| 113 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13162309 |
| 114 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12606010 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12308568 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12033044 |
| 117 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11999515 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11815711 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10092196 |
| 120 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09598810 |
| 121 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.08865587 |
| 122 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08815651 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08150157 |
| 124 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.08006310 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07627598 |
| 126 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06706374 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05279616 |
| 128 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03493564 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03299834 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02863607 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02149850 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 1.01718287 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.01711015 |
| 134 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01479438 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01246307 |
| 136 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00996889 |
| 137 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.98177760 |
| 138 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98067413 |
| 139 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94620260 |
| 140 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93704101 |
| 141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93147883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.36599047 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.27363793 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.00920700 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.97859271 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.92037408 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.86165122 |
| 7 | MP0005671_abnormal_response_to | 2.84917811 |
| 8 | MP0003436_decreased_susceptibility_to | 2.70145183 |
| 9 | MP0005451_abnormal_body_composition | 2.65630119 |
| 10 | MP0009840_abnormal_foam_cell | 2.60511045 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.44217544 |
| 12 | MP0009785_altered_susceptibility_to | 2.41657997 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.34433119 |
| 14 | MP0002419_abnormal_innate_immunity | 2.33487994 |
| 15 | MP0008260_abnormal_autophagy | 2.24403290 |
| 16 | MP0005083_abnormal_biliary_tract | 2.15329863 |
| 17 | MP0005025_abnormal_response_to | 2.13565669 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 2.12539788 |
| 19 | MP0000490_abnormal_crypts_of | 2.09474118 |
| 20 | MP0000685_abnormal_immune_system | 2.05965548 |
| 21 | MP0004381_abnormal_hair_follicle | 2.05305259 |
| 22 | MP0001873_stomach_inflammation | 2.04920364 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 2.03820470 |
| 24 | MP0005365_abnormal_bile_salt | 2.03515240 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.01013920 |
| 26 | MP0001800_abnormal_humoral_immune | 2.00324577 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.99404351 |
| 28 | MP0001819_abnormal_immune_cell | 1.96812265 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.96523894 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.94607653 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.93612204 |
| 32 | MP0002723_abnormal_immune_serum | 1.92014479 |
| 33 | MP0002398_abnormal_bone_marrow | 1.83771848 |
| 34 | MP0004947_skin_inflammation | 1.81772338 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.74016475 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.72976893 |
| 37 | MP0000716_abnormal_immune_system | 1.70536281 |
| 38 | MP0004147_increased_porphyrin_level | 1.68666380 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.67676937 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.67561145 |
| 41 | MP0005360_urolithiasis | 1.66004563 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.64482131 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.63728811 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.63245391 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.61096826 |
| 46 | MP0002429_abnormal_blood_cell | 1.59146991 |
| 47 | MP0002722_abnormal_immune_system | 1.57885905 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.57745163 |
| 49 | MP0003866_abnormal_defecation | 1.57290860 |
| 50 | MP0005387_immune_system_phenotype | 1.54722908 |
| 51 | MP0001790_abnormal_immune_system | 1.54722908 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.49653695 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.48295094 |
| 54 | MP0002405_respiratory_system_inflammati | 1.44385272 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.43745511 |
| 56 | MP0008469_abnormal_protein_level | 1.40665547 |
| 57 | MP0003303_peritoneal_inflammation | 1.39138522 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.38335975 |
| 59 | MP0004858_abnormal_nervous_system | 1.37040060 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.29972418 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.26765130 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.26765130 |
| 63 | MP0003724_increased_susceptibility_to | 1.25920753 |
| 64 | MP0001663_abnormal_digestive_system | 1.25479450 |
| 65 | MP0000858_altered_metastatic_potential | 1.23467720 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.22131628 |
| 67 | MP0001764_abnormal_homeostasis | 1.22062514 |
| 68 | MP0002132_abnormal_respiratory_system | 1.20812930 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.20715569 |
| 70 | MP0006082_CNS_inflammation | 1.18206175 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.17354756 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.15488938 |
| 73 | MP0003693_abnormal_embryo_hatching | 1.14905287 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.13589678 |
| 75 | MP0001853_heart_inflammation | 1.11222309 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10874971 |
| 77 | MP0000609_abnormal_liver_physiology | 1.10136043 |
| 78 | MP0002693_abnormal_pancreas_physiology | 1.09111512 |
| 79 | MP0006054_spinal_hemorrhage | 1.08934010 |
| 80 | MP0003868_abnormal_feces_composition | 1.08829713 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.07352672 |
| 82 | MP0006292_abnormal_olfactory_placode | 1.07099659 |
| 83 | MP0005085_abnormal_gallbladder_physiolo | 1.06519693 |
| 84 | MP0000343_altered_response_to | 1.04519073 |
| 85 | MP0003638_abnormal_response/metabolism_ | 1.02844025 |
| 86 | MP0009764_decreased_sensitivity_to | 1.02139036 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.95732430 |
| 88 | MP0005310_abnormal_salivary_gland | 0.95661580 |
| 89 | MP0001664_abnormal_digestion | 0.95488857 |
| 90 | MP0005501_abnormal_skin_physiology | 0.94076888 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.93534766 |
| 92 | MP0008004_abnormal_stomach_pH | 0.93265414 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.92300094 |
| 94 | MP0003075_altered_response_to | 0.90445685 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.89636399 |
| 96 | MP0002796_impaired_skin_barrier | 0.89417847 |
| 97 | MP0003329_amyloid_beta_deposits | 0.89019947 |
| 98 | MP0002933_joint_inflammation | 0.87663352 |
| 99 | MP0003011_delayed_dark_adaptation | 0.87374238 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.85876517 |
| 101 | MP0001849_ear_inflammation | 0.85487866 |
| 102 | MP0009931_abnormal_skin_appearance | 0.82696097 |
| 103 | MP0005332_abnormal_amino_acid | 0.81959196 |
| 104 | MP0004510_myositis | 0.81953550 |
| 105 | MP0005390_skeleton_phenotype | 0.81590698 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.81237135 |
| 107 | MP0003186_abnormal_redox_activity | 0.81086104 |
| 108 | MP0000598_abnormal_liver_morphology | 0.80377626 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.79366640 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78223216 |
| 111 | MP0002006_tumorigenesis | 0.77986865 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.77503030 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.77322482 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.77005298 |
| 115 | MP0002970_abnormal_white_adipose | 0.76854370 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.75151458 |
| 117 | MP0009763_increased_sensitivity_to | 0.74886468 |
| 118 | MP0008873_increased_physiological_sensi | 0.74366318 |
| 119 | MP0009278_abnormal_bone_marrow | 0.73874636 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.73616601 |
| 121 | MP0008874_decreased_physiological_sensi | 0.72977655 |
| 122 | MP0000371_diluted_coat_color | 0.72477972 |
| 123 | MP0000604_amyloidosis | 0.72182102 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.71097398 |
| 125 | MP0005164_abnormal_response_to | 0.71080275 |
| 126 | MP0001851_eye_inflammation | 0.69840005 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.65822078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.45823949 |
| 2 | Petechiae (HP:0000967) | 4.18969118 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.17576500 |
| 4 | Thrombocytosis (HP:0001894) | 4.16924130 |
| 5 | IgM deficiency (HP:0002850) | 4.06219514 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.80521739 |
| 7 | Aplastic anemia (HP:0001915) | 3.78449384 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55203235 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44404015 |
| 10 | Myositis (HP:0100614) | 3.42799863 |
| 11 | Pustule (HP:0200039) | 3.36364306 |
| 12 | Reduced antithrombin III activity (HP:0001976) | 3.31965535 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.23740742 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.22142219 |
| 15 | Chronic otitis media (HP:0000389) | 3.14513606 |
| 16 | Agnosia (HP:0010524) | 3.12840978 |
| 17 | Dysostosis multiplex (HP:0000943) | 2.99924037 |
| 18 | Increased serum ferritin (HP:0003281) | 2.97436649 |
| 19 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.96202386 |
| 20 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.93949730 |
| 21 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.93949730 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.93949730 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.93949730 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 2.91468373 |
| 25 | Hypertensive crisis (HP:0100735) | 2.84722322 |
| 26 | Hemorrhage of the eye (HP:0011885) | 2.84232783 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 2.83522161 |
| 28 | Amyloidosis (HP:0011034) | 2.79262394 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76570897 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76570897 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76570897 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.76095051 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.72328642 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71827884 |
| 35 | Obstructive lung disease (HP:0006536) | 2.71827884 |
| 36 | Deep venous thrombosis (HP:0002625) | 2.71725403 |
| 37 | Epistaxis (HP:0000421) | 2.66451399 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.65983767 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.65983767 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.64911350 |
| 41 | Meningitis (HP:0001287) | 2.63376285 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62250989 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61781798 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61781798 |
| 45 | Recurrent skin infections (HP:0001581) | 2.60537367 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.57730547 |
| 47 | Thoracic kyphosis (HP:0002942) | 2.56096454 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.53797775 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.51764631 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51764631 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.51330422 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40076924 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40076924 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40076924 |
| 55 | Increased IgE level (HP:0003212) | 2.39873588 |
| 56 | Polygenic inheritance (HP:0010982) | 2.39647143 |
| 57 | Seborrheic dermatitis (HP:0001051) | 2.39006279 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.38838923 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.38231093 |
| 60 | Abnormality of iron homeostasis (HP:0011031) | 2.37873658 |
| 61 | Reticulocytopenia (HP:0001896) | 2.33590832 |
| 62 | Recurrent viral infections (HP:0004429) | 2.32845758 |
| 63 | Increased IgM level (HP:0003496) | 2.31523077 |
| 64 | Stomatitis (HP:0010280) | 2.29051253 |
| 65 | Microretrognathia (HP:0000308) | 2.26715260 |
| 66 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.26309439 |
| 67 | Impaired platelet aggregation (HP:0003540) | 2.26124867 |
| 68 | Abnormal platelet function (HP:0011869) | 2.26124867 |
| 69 | Purpura (HP:0000979) | 2.26023142 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.23274590 |
| 71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20562975 |
| 72 | Periodontitis (HP:0000704) | 2.20182935 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.19765126 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.19448755 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.18361036 |
| 76 | Abnormality of the thoracic spine (HP:0100711) | 2.17473370 |
| 77 | Neutropenia (HP:0001875) | 2.16964995 |
| 78 | Lymphopenia (HP:0001888) | 2.16613924 |
| 79 | Encephalitis (HP:0002383) | 2.16168023 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.16030757 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15994892 |
| 82 | Poor head control (HP:0002421) | 2.15222948 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.13409696 |
| 84 | Cholecystitis (HP:0001082) | 2.10859635 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.10859635 |
| 86 | Albinism (HP:0001022) | 2.09796477 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.09371001 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.08864204 |
| 89 | B lymphocytopenia (HP:0010976) | 2.08864204 |
| 90 | Agammaglobulinemia (HP:0004432) | 2.07484105 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03689753 |
| 92 | Granulocytopenia (HP:0001913) | 2.02892206 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02777374 |
| 94 | Colitis (HP:0002583) | 2.01640433 |
| 95 | Joint stiffness (HP:0001387) | 2.00834830 |
| 96 | Xanthomatosis (HP:0000991) | 2.00191713 |
| 97 | Pancytopenia (HP:0001876) | 1.99752311 |
| 98 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99595141 |
| 99 | Prolonged neonatal jaundice (HP:0006579) | 1.98782437 |
| 100 | Vasculitis (HP:0002633) | 1.98500189 |
| 101 | Villous atrophy (HP:0011473) | 1.98376918 |
| 102 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.98376918 |
| 103 | Papilloma (HP:0012740) | 1.97152741 |
| 104 | Verrucae (HP:0200043) | 1.97152741 |
| 105 | Gingivitis (HP:0000230) | 1.97031318 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96719082 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 1.95965645 |
| 108 | Ragged-red muscle fibers (HP:0003200) | 1.95708322 |
| 109 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95643079 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.95056078 |
| 111 | Fatigue (HP:0012378) | 1.94094741 |
| 112 | Poikiloderma (HP:0001029) | 1.92800131 |
| 113 | Cellulitis (HP:0100658) | 1.90994331 |
| 114 | Abnormality of T cells (HP:0002843) | 1.90979238 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90102725 |
| 116 | Rough bone trabeculation (HP:0100670) | 1.89670249 |
| 117 | Broad face (HP:0000283) | 1.88561853 |
| 118 | Hypokinesia (HP:0002375) | 1.88434345 |
| 119 | Viral hepatitis (HP:0006562) | 1.87954618 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.87933920 |
| 121 | Pallor (HP:0000980) | 1.87327499 |
| 122 | Chronic diarrhea (HP:0002028) | 1.87299067 |
| 123 | Stridor (HP:0010307) | 1.86771867 |
| 124 | Beaking of vertebral bodies (HP:0004568) | 1.86208190 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.85886488 |
| 126 | Hepatic necrosis (HP:0002605) | 1.85741905 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.84215240 |
| 128 | Limb hypertonia (HP:0002509) | 1.82212240 |
| 129 | Severe visual impairment (HP:0001141) | 1.81264169 |
| 130 | Nasal polyposis (HP:0100582) | 1.81235832 |
| 131 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80570350 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.80315817 |
| 133 | Chest pain (HP:0100749) | 1.80296047 |
| 134 | Menorrhagia (HP:0000132) | 1.79293052 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.78303507 |
| 136 | Pulmonary infiltrates (HP:0002113) | 1.77778498 |
| 137 | Gingival bleeding (HP:0000225) | 1.76776780 |
| 138 | Orchitis (HP:0100796) | 1.76457976 |
| 139 | Urticaria (HP:0001025) | 1.76397439 |
| 140 | Entropion (HP:0000621) | 1.75267946 |
| 141 | Reticulocytosis (HP:0001923) | 1.74410416 |
| 142 | Hepatitis (HP:0012115) | 1.71769503 |
| 143 | Loss of speech (HP:0002371) | 1.67931854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.71562567 |
| 2 | SMG1 | 3.52716055 |
| 3 | STK16 | 3.27770901 |
| 4 | BCKDK | 3.00550902 |
| 5 | KIT | 2.96806525 |
| 6 | MAP2K3 | 2.96028336 |
| 7 | FLT3 | 2.76060409 |
| 8 | ERN1 | 2.74305978 |
| 9 | VRK2 | 2.59088807 |
| 10 | BLK | 2.50570835 |
| 11 | MAP3K12 | 2.36502006 |
| 12 | ZAP70 | 2.24725769 |
| 13 | PRPF4B | 2.24209212 |
| 14 | IRAK4 | 2.23883732 |
| 15 | MAP3K6 | 2.19107678 |
| 16 | BTK | 2.12797715 |
| 17 | CSF1R | 2.10040671 |
| 18 | NME2 | 2.08895805 |
| 19 | SIK1 | 2.07205687 |
| 20 | TAOK3 | 2.01154643 |
| 21 | EIF2AK3 | 2.00721284 |
| 22 | EEF2K | 1.89884406 |
| 23 | PIM2 | 1.87872282 |
| 24 | RIPK4 | 1.85266812 |
| 25 | FES | 1.81057035 |
| 26 | SYK | 1.69881789 |
| 27 | CAMKK2 | 1.61406974 |
| 28 | SCYL2 | 1.60812026 |
| 29 | TEC | 1.60433655 |
| 30 | TXK | 1.53940266 |
| 31 | MATK | 1.52134198 |
| 32 | EPHA2 | 1.47242421 |
| 33 | TBK1 | 1.46065889 |
| 34 | GRK6 | 1.44942182 |
| 35 | MAP3K11 | 1.44215947 |
| 36 | PKN2 | 1.40378682 |
| 37 | FGFR4 | 1.39657844 |
| 38 | MAP3K3 | 1.31645104 |
| 39 | TYK2 | 1.27334780 |
| 40 | BUB1 | 1.26578947 |
| 41 | SIK3 | 1.24937833 |
| 42 | VRK1 | 1.23430573 |
| 43 | TAOK2 | 1.21748973 |
| 44 | CLK1 | 1.20369865 |
| 45 | ICK | 1.19999232 |
| 46 | MAP2K6 | 1.15735102 |
| 47 | ADRBK2 | 1.12883302 |
| 48 | TRIB3 | 1.09298324 |
| 49 | CDK8 | 1.08313761 |
| 50 | PAK4 | 1.07872065 |
| 51 | MAP3K14 | 1.07533888 |
| 52 | TESK1 | 1.06847781 |
| 53 | LYN | 1.06196032 |
| 54 | BRSK2 | 1.01353003 |
| 55 | PRKD2 | 0.96585348 |
| 56 | TNK2 | 0.96032608 |
| 57 | LRRK2 | 0.95459921 |
| 58 | PTK6 | 0.94414460 |
| 59 | STK10 | 0.92409892 |
| 60 | CDK12 | 0.91608131 |
| 61 | DAPK1 | 0.90767579 |
| 62 | CCNB1 | 0.90431958 |
| 63 | MAP3K13 | 0.88361263 |
| 64 | MAPKAPK5 | 0.88300112 |
| 65 | MAPKAPK3 | 0.85655716 |
| 66 | JAK3 | 0.84410992 |
| 67 | MARK2 | 0.84203983 |
| 68 | TAF1 | 0.83085105 |
| 69 | TNIK | 0.79296923 |
| 70 | LMTK2 | 0.79034935 |
| 71 | MAP3K7 | 0.78234131 |
| 72 | CDK19 | 0.76693658 |
| 73 | PDPK1 | 0.75942515 |
| 74 | EIF2AK1 | 0.75613031 |
| 75 | PASK | 0.74870740 |
| 76 | HCK | 0.74861410 |
| 77 | LCK | 0.74168930 |
| 78 | RPS6KB2 | 0.71948599 |
| 79 | CDC42BPA | 0.71871005 |
| 80 | PDK1 | 0.68059898 |
| 81 | MELK | 0.65895314 |
| 82 | RAF1 | 0.62922608 |
| 83 | NME1 | 0.62776204 |
| 84 | TESK2 | 0.61366673 |
| 85 | MAPK4 | 0.61300813 |
| 86 | DYRK1B | 0.59866192 |
| 87 | BRSK1 | 0.59429723 |
| 88 | MAP3K1 | 0.59035979 |
| 89 | IKBKB | 0.58564685 |
| 90 | IRAK3 | 0.57929965 |
| 91 | MST1R | 0.57286745 |
| 92 | BMX | 0.56866020 |
| 93 | IKBKE | 0.56778300 |
| 94 | MAP3K5 | 0.56193748 |
| 95 | EPHB1 | 0.55987680 |
| 96 | MAP2K4 | 0.55504794 |
| 97 | FGR | 0.54879547 |
| 98 | CAMKK1 | 0.54641048 |
| 99 | CHUK | 0.53446948 |
| 100 | PIM1 | 0.53238785 |
| 101 | KDR | 0.51865647 |
| 102 | CDK9 | 0.51174779 |
| 103 | ITK | 0.50376805 |
| 104 | MTOR | 0.50191202 |
| 105 | MAPKAPK2 | 0.49439688 |
| 106 | MAPK12 | 0.49004135 |
| 107 | MAP3K10 | 0.47323572 |
| 108 | RPS6KA6 | 0.45512430 |
| 109 | MAP3K8 | 0.45119322 |
| 110 | TSSK6 | 0.43798989 |
| 111 | MARK3 | 0.43112192 |
| 112 | ARAF | 0.41935632 |
| 113 | PRKCD | 0.41826572 |
| 114 | TLK1 | 0.41030154 |
| 115 | MYLK | 0.40295558 |
| 116 | PRKG2 | 0.39545223 |
| 117 | BRAF | 0.39092029 |
| 118 | TAOK1 | 0.38918036 |
| 119 | RPS6KA2 | 0.38074250 |
| 120 | MAPK11 | 0.37892452 |
| 121 | CDK7 | 0.37521763 |
| 122 | CDK4 | 0.37485509 |
| 123 | CSK | 0.37439758 |
| 124 | MAP2K2 | 0.37024474 |
| 125 | STK38 | 0.36908719 |
| 126 | IRAK2 | 0.36077335 |
| 127 | WEE1 | 0.36072907 |
| 128 | JAK1 | 0.36031874 |
| 129 | ATR | 0.34541406 |
| 130 | TGFBR2 | 0.33540431 |
| 131 | PIK3CG | 0.33253050 |
| 132 | RPS6KL1 | 0.32859874 |
| 133 | RPS6KC1 | 0.32859874 |
| 134 | ILK | 0.31106621 |
| 135 | INSRR | 0.29516111 |
| 136 | TGFBR1 | 0.27442981 |
| 137 | HIPK2 | 0.26619989 |
| 138 | SIK2 | 0.26526966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.17579422 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.12212368 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.97350260 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.62058816 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.52950533 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.47641181 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.40472325 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.34179325 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.32667671 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.20480252 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.08291109 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90551051 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89705385 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.79167682 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.73833991 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.73386400 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.70997372 |
| 18 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.66939941 |
| 19 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.65850514 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.61314934 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.59623384 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58633511 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52580207 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50699841 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48180262 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42531034 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42294624 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.40988570 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40247599 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.39692632 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39336229 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.35678601 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35241799 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32469043 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.29633936 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29056147 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26633742 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25620833 |
| 39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.25604344 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.24225121 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.22456953 |
| 42 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.20625782 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19420677 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15106806 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14789408 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12181509 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11421595 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10775532 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09813468 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09023726 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06849693 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06386947 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.05506343 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.04843484 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03218481 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03134594 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02877466 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01549419 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 1.00881687 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 1.00761732 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99602180 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94889329 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94612964 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90982936 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89768843 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88181158 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87461734 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85587205 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85058476 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84870530 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84226042 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.83741765 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80469963 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79732779 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79587839 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78235325 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.77940760 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.77872750 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75920499 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75165270 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74802929 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.74746456 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74210869 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72443843 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71019413 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68428244 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.66964590 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66383770 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66286609 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.65796152 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65280343 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.64963351 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64557448 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.63888313 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63831819 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63509870 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62641066 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62051136 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61428406 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61330206 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61236648 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58681971 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.58468324 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57771981 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56870856 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56857290 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56119493 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55625769 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53962591 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53653384 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.52184222 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51460940 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50123761 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.49076913 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48894585 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48753731 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.48589131 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48031355 |
| 119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46055944 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46020948 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45994168 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.45762556 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44899682 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43444973 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.43426722 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43321144 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43177204 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42523096 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42420635 |
| 130 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41797683 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41251697 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39667174 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39576879 |
| 134 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39543356 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38135003 |
| 136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37633543 |
| 137 | Apoptosis_Homo sapiens_hsa04210 | 0.36747466 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35945261 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35875473 |

